9FX Stock Overview

An ophthalmic pharmaceutical company, engages in the research, development, manufacture, and commercialization of therapies that address unmet medical needs in the People’s Republic of China, South Korea, and Hong Kong. More details

9FX fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	2/6
Past Performance	0/6
Financial Health	6/6
Dividends	0/6

Rewards

Revenue is forecast to grow 72.63% per year

Earnings have grown 27.5% per year over the past 5 years

Risk Analysis

Shares are highly illiquid

Currently unprofitable and not forecast to become profitable over the next 3 years

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

My Notes

Capture your thoughts, links and company narrative

Zhaoke Ophthalmology Limited Competitors

MPH Health Care

DB:93M1

€97.6m

PharmaSGP Holding

XTRA:PSG

€299.8m

Apontis Pharma

XTRA:APPH

€94.1m

Cantourage Group

XTRA:HIGH

€58.6m

Price History & Performance

Summary of share price highs, lows and changes for Zhaoke Ophthalmology
Historical stock prices
Current Share Price	HK$0.23
52 Week High	HK$0.23
52 Week Low	HK$0.18
Beta	1.09
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	15.15%

Recent updates

Shareholder Returns

	9FX	DE Pharmaceuticals	DE Market
7D	14.0%	-1.2%	-0.08%
1Y	n/a	-13.2%	16.8%

Return vs Industry: Insufficient data to determine how 9FX performed against the German Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how 9FX performed against the German Market.

Price Volatility

Is 9FX's price volatile compared to industry and market?
9FX volatility
9FX Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	4.5%
Market Average Movement	5.2%
10% most volatile stocks in DE Market	11.6%
10% least volatile stocks in DE Market	2.8%

Stable Share Price: 9FX's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine 9FX's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2017	297	Benjamin Li	www.zkoph.com

Zhaoke Ophthalmology Limited, an ophthalmic pharmaceutical company, engages in the research, development, manufacture, and commercialization of therapies that address unmet medical needs in the People’s Republic of China, South Korea, and Hong Kong. It is developing various drugs that cover ophthalmic indications, including dry eye diseases, wet age-related macular degeneration, diabetic macular edema, myopia, and glaucoma. The company was formerly known as China Ophthalmology Focus Limited.

Zhaoke Ophthalmology Limited Fundamentals Summary

How do Zhaoke Ophthalmology's earnings and revenue compare to its market cap?
9FX fundamental statistics
Market cap	€136.24m
Earnings (TTM)	-€28.88m
Revenue (TTM)	€7.28m

18.0x

P/S Ratio

-4.5x

P/E Ratio

Is 9FX overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
9FX income statement (TTM)
Revenue	CN¥57.22m
Cost of Revenue	CN¥10.28m
Gross Profit	CN¥46.93m
Other Expenses	CN¥274.00m
Earnings	-CN¥227.06m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Mar 24, 2025

Earnings per share (EPS)	-0.42
Gross Margin	82.03%
Net Profit Margin	-396.86%
Debt/Equity Ratio	11.0%

How did 9FX perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/03/10 19:31
End of Day Share Price	2025/03/07 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Zhaoke Ophthalmology Limited is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Ziyi Chen	Goldman Sachs
Yue-Kwong Lui	Jefferies LLC

Zhaoke Ophthalmology DB:9FX Stock Report